Sanofi
SNY
$59.15
$1.452.51%
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -10.23% | 0.33% | |
| Total Other Revenue | -- | -- | 37.26% | 30.29% | |
| Total Revenue | -- | -- | -7.74% | 1.73% | |
| Cost of Revenue | -- | -- | -5.80% | 2.24% | |
| Gross Profit | -- | -- | -8.57% | 1.51% | |
| SG&A Expenses | -- | -- | -12.73% | 1.31% | |
| Depreciation & Amortization | -- | -- | -4.81% | 1.42% | |
| Other Operating Expenses | -- | -- | 129.70% | 72.21% | |
| Total Operating Expenses | -- | -- | -0.38% | 5.46% | |
| Operating Income | -- | -- | -31.61% | -10.85% | |
| Income Before Tax | -- | -- | -40.39% | 43.23% | |
| Income Tax Expenses | -- | -- | -47.76% | 59.88% | |
| Earnings from Continuing Operations | -- | -- | -38.66% | 39.74% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | 67.39% | -40.77% | |
| Net Income | -- | -- | -34.13% | 39.73% | |
| EBIT | -- | -- | -31.61% | -10.85% | |
| EBITDA | -- | -- | -23.24% | -6.47% | |
| EPS Basic | -- | -- | -34.12% | 39.70% | |
| Normalized Basic EPS | -- | -- | -55.37% | -1.67% | |
| EPS Diluted | -- | -- | -34.18% | 39.61% | |
| Normalized Diluted EPS | -- | -- | -55.37% | -1.67% | |
| Average Basic Shares Outstanding | -- | -- | -0.05% | -0.03% | |
| Average Diluted Shares Outstanding | -- | -- | 0.04% | -0.03% | |
| Dividend Per Share | -- | -- | 11.29% | -4.47% | |
| Payout Ratio | -- | -- | -- | -- | |
